Results 21 to 30 of about 6,393 (198)
A case of mucocutaneous leishmaniasis [PDF]
Otolaryngology–Head and Neck Surgery, 2002 Leishmaniasis is prevalent in most warm-climate areas of the world. We describe a long-undiagnosed case of mucocutaneous leishmaniasis in Italy that might have been contracted in Costa Rica. The patient's signs and symptoms included granulomatous-like lesions on the forehead and legs, nasal obstruction accompanied by serous and crusted rhinorrhea, and ...
Gina R. Virgilio, Braden R. Hale
openaire +6 more sources
Hybrid reference genome assemblies for <i>Leishmania (Viannia) braziliensis</i>, a primary agent of mucocutaneous leishmaniasis. [PDF]
Microbiol Resour AnnouncWe report high-quality long-read genome assemblies and annotations for two widely studied reference strains of Leishmania (Viannia) braziliensis , a primary agent of cutaneous and mucocutaneous leishmaniasis.
Cotton JA +5 more
europepmc +2 more sources
The Egyptian Journal of Internal Medicine, 2023 Leishmaniasis is a protozoal infection transmitted by sandfly vector; there are three main types of leishmaniasis: cutaneous leishmaniasis (CL), mucocutaneous leishmaniasis (MCL), and visceral leishmaniasis (VL).
Hamdi Ibrahim +6 more
doaj +1 more source
Orofacial manifestations of mucocutaneous leishmaniasis: a case series from Brazil [PDF]
F1000Research, 2019 Gleicy Gabriela Vitoria Spinola Carneiro Falcao +2 more
exaly +2 more sources
Our Dermatology Online, 2022 Leishmaniasis is a parasitosis caused by protozoa of the genus Leishmania (L.) transmitted by the bite of the sandfly Phlebotomus [1]. In Morocco, there exist three species: L. infantum, L. major, and L. tropica, most often responsible for the cutaneous and visceral forms.
Layla Bendaoud, O. Hocar, S. Amal
openaire +1 more source
Leishmaniasis: new approaches to disease control. [PDF]
, 2003 The leishmaniases afflict the world's poorest populations. Among the two million new cases each year in the 88 countries where the disease is endemic (fig 1), it is estimated that 80% earn less than $2 a day.
Croft, Simon L +5 more
core +1 more source
Parenteral aminosidine is not effective for Peruvian mucocutaneous leishmaniasis. [PDF]
, 2007 Few therapeutic options are available for mucocutaneous leishmaniasis (MCL). We conducted a randomized open trial to evaluate the efficacy, safety, and tolerance of parenteral aminosidine sulphate (AS) 14 mg/kg/d for 21 days compared with intravenous ...
Cruz, Maria +8 more
core +1 more source
Multiple hybrid genotypes of Leishmania (viannia) in a focus of mucocutaneous Leishmaniasis. [PDF]
, 2007 The principal agent of mucocutaneous leishmaniasis (MCL) is the South American protozoan parasite Leishmania (Viannia) braziliensis. This organism is generally considered to be clonal, that is, it does not to undergo genetic exchange.
Miles, Michael A +4 more
core +1 more source
Leishmaniasis in the Argentine Republic: Temporal and geographical distribution from 2013 to 2017
Asian Pacific Journal of Tropical Medicine, 2019 Objective: To assess the temporal and geographical distribution of confirmed cases of cutaneous, mucocutaneous and visceral leishmaniasis in the Argentine Republic from 2013 to 2017.
María J Germano +5 more
doaj +1 more source
ZOONOTIC CUTANEOUS LESHMAIASIS THREE YEARS FEVER HOSPITAL RECORDS: WITH GENERAL DISCUSSION [PDF]
Journal of the Egyptian Society of Parasitology, 2016 Leishmaniasis is widely present in more than 88 countries worldwide, resulting in up to 80,000 deaths annually. Leishmaniasis occurs as visceral, cutaneous, or mucocutaneous variants. Mucosal involvement can occur secondarily to the cutaneous or visceral
TOSSON MORSY, AMR ABDEL-MOTAGALY
doaj +1 more source